In this article, we demonstrate that conolidine, a organic analgesic alkaloid used in classic Chinese medicine, targets ACKR3, thereby delivering extra evidence of a correlation in between ACKR3 and soreness modulation and opening alternative therapeutic avenues with the remedy of chronic agony.